Find Academic Supervisors

Leila KarimiView profile

Professor

• Psychology
• Mental Health
• Healthcare Workforce Wellbeing
• +4 more

Professor Leila Karimi is the Assistant Associate Dean of Applied Health at RMIT University's Health and Biomedical Sciences department. She specializes in mental health, healthcare workforce wellbeing, and addictive behaviors. Her research bridges psychology, public health, and clinical interventions, with a focus on meditation's cardiometabolic effects and digital addiction analysis using machine learning. She supervises projects addressing pharmacist well-being, ADHD screening tools, and technology-driven mental health solutions. Key roles: Professor & Assistant Associate Dean (Applied Health) Affiliations: RMIT University, College of Health and Biomedical Sciences Research Themes: Mental Health, Healthcare Workforce Resilience, Digital Behavioral Interventions Her work emphasizes crisis management strategies for healthcare workers and validating tools like the Mediterranean Lifestyle Consensus. Recent studies explore clozapine safety in pregnancy and emotional intelligence training efficacy. She collaborates internationally on projects ranging from Parkinson's stem cell therapies to global obesity epidemiology. Publications span behavioral addictions, clinical psychology, and health systems innovation. She is actively involved in supervising doctoral students exploring meditation, workplace well-being, and digital transformation in healthcare.

George JohnView profile

Senior Lecturer

• Pharmacy Practice
• Medical Education
• Curriculum Development
• +8 more

George John is a Senior Lecturer in Pharmacy Practice and Head of Discipline Medical Science at Charles Sturt University’s School of Dentistry and Medical Sciences. With over 25 years of experience across Africa, Asia, and Australia, he specializes in teaching Pharmacy and Medical Science graduates while leading curriculum innovations. B.Pharm. (India) M.Pharm.Prac. (South Africa) Graduate Certificates in Pharmacoeconomics, Disease Management, University Learning & Teaching, and Leadership & Management (Australia) His research spans pharmacy practice , medical education , generative AI ethics , microbiology , and healthcare process improvement . Recent publications include studies on: Pre-analytical errors in diagnostics (2025) AI depiction bias in pharmacy (2024) Candida auris resistance mechanisms (2024) Online learning modules for medical laboratory students (2024) He has secured $150,000 in competitive grants and supervised over 20 Research Higher Degree students. Active in academic governance via the Academic Senate and Faculty Boards, he also contributes to: NSW Ministry of Health Pharmacy Workforce Planning (2012-2022) Murrumbidgee Local Health District Safety & Quality Committee

Kirsten GalbraithView profile

Professor

• Pharmacy Education
• Competency-Based Education
• Workplace-Based Assessment
• +3 more

Kirsten Galbraith is a Professor in the Department of Pharmacy and Pharmaceutical Sciences Education at Monash University. She holds leadership roles including Course Director for the Master of Clinical Pharmacy and Unit Coordinator for PGC5119 Advanced Practice Portfolio. Her expertise lies in practitioner development, competency-based education, and workplace-based assessment. She leads key programs such as the Skills Coaching program, Student Experiential Placements (StEPs), and the Intern Training Program. Education: MClinPharm, Faculty of Pharmacy and Pharmaceutical Sciences BPharm, Victorian College of Pharmacy Ltd Research focuses on advancing pharmacy education and workforce development, including global frameworks for professional advancement (e.g., FIP Hub initiatives). Her work aligns with UN Sustainable Development Goals, particularly in education and healthcare equity. Key projects include the 'Global Advanced Development Framework' and reducing medication-related risks through competency-based training. Recent articles emphasize entrustable professional activities (EPAs) in pharmacy training, AI in reflective learning, and global workforce resilience strategies. Awards include the American AACP Innovation in Teaching Award (2022) and Fellowships from FIP and SHPA. She leads collaborative grants on reducing medication risks and advancing practice standards. Supervises students like Carmen Abeyaratne (MClinPharm). Active in editorial roles for journals like Research in Social and Administrative Pharmacy and peer review for BMJ Open . Labs/Teams: Co-leads the Graduate Outcomes and Workforce Development group. Collaborates internationally via the FIP Hub and GRiT community for pharmacy workforce resilience.

Gazala AkramView profile

Senior Lecturer

• Mental Health Service Delivery
• Community Pharmacy
• Clinical Pharmacy
• +7 more

Gazala Akram is a Senior Teaching Fellow at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, where she contributes to the MPharm and postgraduate programs. She serves as the Course Director for the MSc in Clinical Pharmacy and has a strong interdisciplinary presence in public health and mental health service delivery. PhD in Clinical Information Provision for Lay Persons in ADHD, University of Strathclyde (2010) Master of Public Health, University of Nottingham (1997) Bachelor of Science, University of Strathclyde (1993) Her research is deeply rooted in her clinical experience, focusing on mental health service delivery , community pharmacy roles , and palliative care . She is particularly interested in expanding the scope of community pharmacists in managing depression and supporting patients with complex psychiatric needs. Her work bridges clinical practice, policy, and education to improve patient outcomes. The recent article trends highlight a consistent focus on community pharmacy interventions in mental health, including depression services, minor ailments, and opioid harm reduction. Her studies employ qualitative and systematic review methodologies, emphasizing stakeholder engagement and real-world implementation challenges in healthcare systems. Fellow of the Royal Pharmaceutical Society (FRPS) (2019, 2024) Developing GP and Community Pharmacy Partnerships Award (2014) Best Research Poster on Clozapine Metabolic Effects (2014) Best Original Research Presentation on ADHD (2010) Gazala Akram has led and contributed to multiple research projects, including those funded by Pharmacy Research UK and Macmillan. She has supervised students and early-career researchers, though specific names are not listed. Her external roles include serving on the GPhC Fitness to Practice Committee and the Scottish Government’s CSO HIPS Research Committee, reflecting her influence in national pharmacy policy and professional standards. She is actively involved in research networks and professional communities, including organizing the NORDIC Social Pharmacy Conference 2025 and participating in multi-institutional collaborations focused on mental health and palliative care service innovation.

• Pharmaceutical Policy Analysis
• Pharmacoepidemiology
• Pharmacovigilance
• +4 more

Prof. Aukje Mantel-Teeuwisse is a Professor of Pharmacy and Global Health at Utrecht University, leading the Undergraduate School of Science since 2023. She holds a PharmD from Utrecht University (1998), followed by a PhD in Pharmacoepidemiology (2004). Her career includes roles as a community pharmacist, academic researcher, and part-time liaison at the Dutch Medicines Evaluation Board (2005–2010). Currently, she also serves as Scientific Director of the WHO Collaborating Centre for Pharmaceutical Policy and Regulation, focusing on global health policy, drug regulation, and pharmaceutical policy analysis. Her research emphasizes global health equity, drug regulatory science, and medicine use variation. Over 200 peer-reviewed articles highlight her contributions to HTA methodologies, oncology drug economics, and access to medicines in low-resource settings. Educationally, she oversees Pharmacy and Drug Innovation programs, advocating for digital transformation in pharmaceutical education. Leadership roles include directing Utrecht’s School of Pharmacy (2014–2023) and contributing to international committees on pharmaceutical policy and healthcare access. Key initiatives include addressing medicine shortages, improving access to childhood cancer treatments, and evaluating policies regulating pharmaceutical supply chains. Her work bridges academia, policy, and global health, with a focus on aligning regulatory, HTA, and clinical guideline practices to enhance healthcare outcomes.

Amanda CrossView profile

Research Fellow

• Medication Safety and Effectiveness
• Quality Use of Medicines
• Dementia Prevention
• +3 more

Dr. Amanda Cross is an NHMRC Emerging Leader Research Fellow at Monash University's Centre for Medicine Use and Safety. Her work focuses on medication safety and quality use in older adults, particularly those at risk of dementia or living with dementia. She holds a PhD from Monash University (2019) and is a credentialed medication management review pharmacist. Dr. Cross leads four Medical Research Future Fund (MRFF) projects, including initiatives to reduce medication-related harm in aged care through knowledge brokers and co-designed resources. She has authored over 40 peer-reviewed articles, with a focus on analgesic use, anticholinergic burden, and guideline implementation. Research Interests: Dr. Cross prioritizes optimizing medication management in residential aged care, deprescribing strategies, and reducing polypharmacy risks. Her work integrates clinical practice, policy, and education to improve outcomes for vulnerable populations. She has pioneered studies analyzing medication practices across 106 nursing homes in 12 countries and developed frameworks for pharmacist integration into aged care settings. Grants & Projects: As Principal Chief Investigator on projects funded by the Department of Health and Aged Care, she leads initiatives such as the EMBRACE trial (testing knowledge broker models) and co-designing medication management resources for dementia care. Her work contributes to UN Sustainable Development Goals related to health equity and aging. Awards: Recognized for her early career contributions, Dr. Cross has received the Pharmaceutical Society of Australia Victorian Early Career Pharmacist of the Year (2019) and was elevated to Fellow status in 2024. She is also a 2023 recipient of Monash University's Neuroscience and Mental Health TPA Publication Award. Labs/Teams: She collaborates with the Australian and New Zealand Musculoskeletal Clinical Trials Network and the Monash Aging Research Centre. Her team includes experts in implementation science, geriatric pharmacy, and dementia care.

Saw Pui SanView profile

Lecturer

• Public Health
• Pharmacy Practice
• Healthcare Workforce Dynamics
• +5 more

Saw Pui San is a Lecturer in the Malaysia School of Pharmacy at Monash University, specializing in public health and pharmacy practice. She focuses on healthcare systems, person-centered care strategies, and workforce dynamics in Malaysia. Her research is funded by grants from the Ministry of Health Malaysia and WHO. She actively reviews for the National Institute of Health Malaysia. Research interests include healthcare access, primary care strengthening, and pharmacy integration into healthcare systems. Her work addresses avoidable hospitalizations, dementia care, and pharmacist roles in vaccination programs. Recent articles highlight digitalization of pharmaceutical supply chains, mental health screening in pharmacies, and person-centered care strategies. She has received multiple teaching awards, including PVC Commendations for Innovations in Education (2020–2022), and led projects on medication management and burnout in pharmacists. She serves on the Malaysian Pharmacists Society Executive and Ministry of Health advisory boards, and organized workshops on safe medication disposal. Her work contributes to UN Sustainable Development Goals related to health equity and planetary wellbeing.

Jacinda C. Abdul-MutakabbirView profile

Adjunct Assistant Professor

• Infectious Diseases
• Antimicrobial Stewardship
• Health Equity
• +3 more

Jacinda C. Abdul-Mutakabbir, PharmD, is an Adjunct Assistant Professor in the Microbiology Division at Loma Linda University School of Medicine. She completed her Doctorate in Pharmacy at the University of Saint Joseph School of Pharmacy and a Masters of Public Health at Wayne State University. Dr. Abdul-Mutakabbir's work focuses on rectifying health inequities in minoritized communities through clinical pharmacy and public health initiatives. Doctorate in Pharmacy: University of Saint Joseph Masters of Public Health: Wayne State University Her research spans infectious disease pharmacokinetics , antimicrobial stewardship , and vaccine equity . Notably, she leads the Loma Linda University COVID-19 Equitable Mobile Vaccination Clinics and has published extensively on Clostridioides difficile disparities, Staphylococcus aureus pharmacokinetics, and equity frameworks for pharmacy practice. Recent publications (2024-2025) emphasize antimicrobial resistance in carceral settings , equitable vaccine delivery , and intersectional approaches to racism and gender inequity . Her work has been recognized by the European Congress of Clinical Microbiology and Infectious Diseases and the United States Public Health Services . 2017 USPHS Outstanding Service Award ECCMID 2021 30 Under 30 Recognition Dr. Abdul-Mutakabbir actively contributes to professional organizations including the American Academy of HIV Medicine , Infectious Diseases Society of America , and Society of Infectious Disease Pharmacists . Her methodological expertise includes non-trapezoidal pharmacokinetic modeling and community-academic partnership interventions .

SOMANATH SHENOYView profile

Professor

• Vascular Biology
• Diabetes Complications
• Drug Discovery
• +5 more

Somanath Shenoay is the Kenneth L. Waters Pharmacy Professor and Assistant Department Head for Research and Graduate Education at the University of Georgia's College of Pharmacy. He serves as Graduate Coordinator and leads research programs focused on vascular biology, diabetes complications, and translational drug discovery. His work integrates clinical pharmacy with molecular mechanisms underlying diseases such as diabetic retinopathy, lung injury, and cancer metastasis. Dr. Shenoay's research emphasizes barrier dysfunction in vascular and neural systems, leveraging drug discovery approaches to target enzymes like SMOX and pathways involving PAK1. He collaborates with the UGA Center for Drug Discovery and UGA Drug Discovery Group to advance therapies for conditions like retinal neurodegeneration and pulmonary hypertension. His studies often employ preclinical models, including spontaneously hypertensive rats and diabetic mice, to evaluate novel compounds. Key contributions include identifying Claudin-17's role in lung injury, demonstrating SMOX inhibition's neuroprotective effects in diabetes, and analyzing biomarkers in acute respiratory distress syndrome (ARDS). His work bridges basic science with clinical applications, addressing unmet needs in cardiovascular, pulmonary, and ophthalmic medicine. Awarded the Fellow of the American Heart Association (FAHA), Dr. Shenoay has secured grant support for projects targeting vascular permeability, cancer metastasis, and drug delivery systems. He actively mentors trainees in pharmacist clinician-scientist pathways and contributes to interprofessional education initiatives.

• Pharmacogenomics
• Pharmacist-led interventions
• Pharmacy education
• +5 more

Dr. Chiao Xin Lim is a Senior Lecturer in the Department of Health and Biomedical Sciences at RMIT University. Her research focuses on pharmacogenomics implementation, culturally competent healthcare interventions, digital health innovation, and pharmacy education. She coordinates third-year undergraduate pharmacy practice courses and supervises research projects addressing medication adherence in culturally diverse populations. Professional roles include General Council member and Education Representative for the Australasian Pharmaceutical Science Association (2023-24) and membership in the Pharmaceutical Society of Australia. Key research interests span asthma self-management in Middle Eastern Arabic-speaking refugees, palliative care pharmacist roles, and educational strategies for cultural competence in health professions. Dr. Lim's teaching innovations include case-based learning for cultural competence and interprofessional simulations between nursing/pharmacy students. She has pioneered validated tools for asthma inhaler technique assessment in Arabic-speaking populations and developed survey instruments for oncology pharmacogenomics education needs. Supervision Focus: Culturally responsive healthcare strategies for cardiovascular, diabetes, and respiratory conditions Key Projects: Pharmacogenomics implementation in oncology, digital health interventions for medication adherence, and policy analysis for asylum seeker health equity Labs/Teams: Actively involved in multidisciplinary research teams addressing healthcare disparities and pharmacist-led interventions. Collaborates with international partners on translational research projects.

Mark MorganView profile

Professor

• Patient Safety
• Primary Care Data
• Shared Decision Making
• +8 more

Professor Mark Morgan is a distinguished academic and clinician at Bond University's Faculty of Health Sciences & Medicine, where he serves as Associate Dean for External Engagement and Professor in the Department of General Practice. With extensive experience in both clinical practice and research, he has established himself as a leader in primary care research and policy development in Australia. Professor at Bond University, Faculty of Health Sciences & Medicine Associate Dean for External Engagement Chair of the RACGP Expert Committee for Quality Care Active researcher with numerous recent publications Professor Morgan's research interests span multiple critical areas in primary care including patient safety, management of patients with multiple long-term conditions, shared decision making, and deprescribing. His work bridges clinical practice and health policy, with significant contributions to understanding how healthcare systems can deliver better outcomes for patients. His research often focuses on translating evidence into practice improvements within general practice settings. His recent publications demonstrate expertise across diverse areas including antimicrobial stewardship, medication safety, end-of-life care in general practice, and the management of multimorbidity. The research output shows a strong trajectory with increasing publication activity in recent years, particularly in high-impact areas of primary care. Professor Morgan actively contributes to national health policy through his roles on the Health Care Homes Implementation Advisory Group and the Medicare Benefits Review General Practice and Primary Care Clinical Committee. His policy work focuses on improving healthcare systems, digital health record safety, and medical benefits scheduling. As an educator, Professor Morgan teaches within Bond University's Medical Program and holds a Graduate Certificate in Clinical Education from Flinders University. His educational expertise complements his clinical and research activities, creating a comprehensive academic profile that strengthens medical education at Bond University.

• Interprofessional Education
• Healthcare Collaboration
• Medical Education
• +3 more

Scott Reeves is a Professor at Kingston University, specializing in interprofessional education and healthcare collaboration. His work focuses on enhancing collaboration among healthcare professionals through research and educational initiatives. He has co-authored over 200 articles, books, and guidelines addressing interprofessional teamwork, patient-centered care, and healthcare education systems. His research explores challenges and opportunities in interprofessional practice, including studies on discharge collaboration, interprofessional training, and the integration of pharmacists in primary care. Reeves has contributed to frameworks like the InterProfessional Activity Classification Tool (InterPACT) and co-edited key texts such as *Interprofessional Teamwork for Health and Social Care*. Reeves' work emphasizes the sociological and organizational aspects of healthcare teams, advocating for evidence-based interprofessional education to improve patient outcomes. He has engaged in international collaborations, including studies in Italy, Brazil, and Canada, and his methodologies include ethnography, systematic reviews, and mixed-methods research.

Ian CoombesView profile

Professor

• Clinical Pharmacy
• Medication Safety
• Prescribing Errors
• +7 more

Professor Ian Coombes is a Conjoint Professor at the School of Pharmacy and Pharmaceutical Sciences within the Faculty of Health, Medicine and Behavioural Sciences at the University of Queensland. With extensive experience in clinical pharmacy practice, education, and research, Professor Coombes contributes significantly to medication safety, prescribing practices, and patient-centered pharmaceutical care. His educational background includes a Bachelor (Honours) of Pharmacy from London School of Pharmacy, a Masters (Coursework) of Clinical Pharmacy from the University of Brighton, and a Doctor of Philosophy from The University of Queensland. Professor Coombes' research focuses on critical areas of pharmacy practice including medication safety, clinical pharmacy interventions, cardiovascular disease management, and pharmacy workforce development. His work particularly emphasizes: Pharmacist-led transition of care services Quality use of medicines Prescribing error reduction Pharmaceutical care bundle implementation International capacity building in clinical pharmacy Professional identity formation in pharmacy education His recent publication trends show a strong emphasis on cardiovascular medication management, with numerous studies examining pharmacist interventions in acute coronary syndrome and post-MI care. He has also pioneered work in developing clinical pharmacy services in international settings, particularly in Sri Lanka, and continues to advance methodologies for evaluating medication administration safety and pharmaceutical care impact. Professor Coombes has secured significant research funding including the current MRFF grant "REducing hospital re-admission for high-risk CARDiology patients" (2023-2027) and previously led projects examining heart failure medication management. As an active supervisor, Professor Coombes currently mentors multiple PhD and Master's students on projects related to pharmacist-led medication review, predictive modeling for hospital readmissions, and professional identity formation in pharmacy education. His collaborative approach extends to working with researchers across disciplines including medicine, nursing, and health services research.

Sion ScottView profile

Associate Professor

• Behavioral Medicine
• Health Intervention Development
• Deprescribing
• +3 more

Dr. Sion Scott is an Associate Professor of Behavioural Medicine at the University of Leicester, affiliated with the School of Healthcare's Health behaviour change and implementation science research cluster. He holds a MPharm from the University of East Anglia (2015) and a PhD in Behavioural Science (2016), followed by postdoctoral and lecturing roles before joining Leicester in 2021. His research focuses on applying behavioural science to develop and evaluate health interventions, particularly deprescribing in hospitals and improving medication management for vulnerable populations. Key projects include the NIHR-funded CHARMER study (testing a deprescribing intervention) and the GuiDiR framework for research dissemination. He has contributed to over 50 peer-reviewed articles, emphasizing deprescribing, influenza vaccination strategies, and care home staff health. Dr. Scott collaborates internationally on deprescribing networks and has led grants totaling millions, including an NIHR Programme Grant. His work bridges clinical practice and policy, addressing polypharmacy reduction and patient-centered care.

Rasha Abdelsalam-ElshenawyView profile

Academic

• Antimicrobial Stewardship
• Antimicrobial Resistance
• Public Health
• +4 more

Dr. Rasha Abdelsalam-Elshenawy is a Visiting Lecturer at the University of Hertfordshire's School of Life and Medical Sciences, specializing in antimicrobial stewardship (AMS) and clinical pharmacy. She leads the FADIC Antimicrobial Stewardship School and serves as Director of FADIC Ltd UK. Her research focuses on optimizing antibiotic prescribing, combating antimicrobial resistance (AMR), and evaluating technologies like the SMART-AMS digital model during the pandemic. Educations: PhD in Antimicrobial Stewardship, University of Hertfordshire (2020–2024) PG Diploma in Teaching and Learning, American College of Clinical Pharmacy (2016–2018) Master of Clinical Pharmacy, 2014 Added Qualification in Infectious Diseases, American Board of Pharmacy Specialities, 2018 Research Interests: Her work emphasizes AMS strategies, public health education, and patient safety. She investigates antibiotic prescribing during pandemics and collaborates internationally to advance global health initiatives. Grants & Advising: She leads a five-year AMS strategic plan and has supervised over 100 lectures and final projects. Her roles include NHS research fellowships and contributions to the CDC AMR Challenge. Labs & Teams: Engaged with the Public Health and Patient Safety Unit and Centre for Health Services and Clinical Research at the University of Hertfordshire.